- Investing Ideas
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
6
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
6 companies
AstraZeneca
Market Cap: UK£213.0b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£138.02
7D
-0.8%
1Y
28.7%
Gilead Sciences
Market Cap: US$166.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$136.22
7D
4.4%
1Y
22.6%
Chugai Pharmaceutical
Market Cap: JP¥13.0t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,892.00
7D
-2.4%
1Y
4.1%
Orion Oyj
Market Cap: €10.0b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€71.60
7D
0.5%
1Y
19.8%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥40.4b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥89.72
7D
-2.8%
1Y
-8.4%
Xiamen Amoytop Biotech
Market Cap: CN¥23.1b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥56.55
7D
-1.7%
1Y
-26.8%